Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from February 10 to February 12, 2026 [1] Group 1 - The company confirmed that its production and operations are normal, and there are no significant changes in the external environment [1] - There are no undisclosed significant information apart from what has already been disclosed [1] - No media reports or market rumors have been found that could significantly impact the stock price, and the company is not involved in any market hot concepts [1] Group 2 - During the period of stock price fluctuation, the company's directors, senior executives, controlling shareholders, and actual controllers did not engage in any buying or selling of the company's stock [1] - The company reminds investors to pay attention to trading risks and to invest rationally [1]

Core Viewpoint - The A-share market saw a significant rally in the chemical sector, with multiple stocks experiencing substantial gains on February 12, indicating strong investor interest and potential growth in this industry [1]. Group 1: Stock Performance - Changhua Chemical (301518) rose by 10.57%, with a total market capitalization of 65.46 billion and a year-to-date increase of 26.51% [2]. - Meibang Shares (605033) increased by 10.00%, with a market cap of 35.23 billion and a year-to-date rise of 29.78% [2]. - Jianxin Shares (300107) saw a gain of 9.80%, with a market value of 49.19 billion and a year-to-date increase of 28.15% [2]. - Weike Technology (301196) grew by 8.98%, with a market capitalization of 108 billion and a year-to-date increase of 7.65% [2]. - Kexin Source (300731) increased by 6.92%, with a market cap of 83.04 billion and a year-to-date rise of 16.83% [2]. - Huide Technology (603192) rose by 5.80%, with a market value of 39.31 billion and a year-to-date increase of 5.68% [2]. - New Jinlu (000510) saw a gain of 5.58%, with a market capitalization of 113 billion and a year-to-date increase of 50.26% [2]. - Zhenhua Shares (603067) increased by 5.38%, with a market cap of 263 billion and a year-to-date rise of 28.57% [2]. - ST Yatai (000691) rose by 5.02%, with a market value of 41.56 billion and a year-to-date increase of 21.56% [2]. - Guangkang Biochemical (300804) increased by 4.00%, with a market cap of 33.87 billion and a year-to-date rise of 30.77% [2]. - Hangjin Technology (000818) saw a gain of 4.00%, with a market capitalization of 163 billion and a year-to-date increase of 28.03% [2]. - Hongda Shares (600331) rose by 3.98%, with a market value of 463 billion and a year-to-date increase of 36.90% [2]. - Demei Chemical (002054) increased by 3.31%, with a market cap of 52.65 billion and a year-to-date rise of 47.97% [2]. - Huangma Technology (603181) saw a gain of 3.17%, with a market capitalization of 99.49 billion and a year-to-date increase of 18.26% [2]. - Runmu Materials (300727) rose by 3.14%, with a market value of 65.73 billion and a year-to-date increase of 2.38% [2]. - Litong Technology (920225) increased by 3.09%, with a market cap of 38.08 billion and a year-to-date decrease of 6.40% [2].

Core Viewpoint - The A-share market has seen a significant rally in the chemical sector, with multiple companies experiencing substantial gains in their stock prices [1] Group 1: Company Performance - Changhua Chemical has increased by over 10% [1] - Meibang Co. has reached a 10% limit up [1] - Jianxin Co. has risen by over 9% [1] - Weike Technology has gained over 8% [1] - Kexin Innovation Source has increased by over 6% [1] - Huide Technology, Xinjin Road, and Zhenhua Co. have all risen by over 5% [1]

Group 1 - The company Meibang Co., Ltd. announced that as of the date of the announcement, the total amount of guarantees provided for its wholly-owned subsidiaries is 800 million yuan, which accounts for 71.13% of the company's audited net assets for the year 2024 [1] - As of the date of the announcement, the total balance of guarantees actually provided by the company for its wholly-owned subsidiaries within the scope of consolidated financial statements is 287 million yuan, representing 25.52% of the company's audited net assets for the year 2024 [1] Group 2 - The central bank, which has been the largest buyer of gold for two consecutive years, announced plans to purchase an additional 150 tons of gold, aiming to accumulate a total of 700 tons [1]

证券代码：605033 证券简称：美邦股份 公告编号：2026-003 陕西美邦药业集团股份有限公司 关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | 被担保人名称 | 本次担保金额 | 实际为其提供的担 | | 是否在前 | 本次担保 | | --- | --- | --- | --- | --- | --- | | | | 保余额（不含本次担 | | 期预计额 | 是否有反 | | | | 保金额） | | 度内 | 担保 | | 陕西诺正生物 科技有限公司 | 8,000.00 万元 | 6,700.00 | 万元 | 是 | 否 | 截至本公告披露日，诺正生物的担保预计额度使用情况如下： 单位：万元人民币 | 被担保方 | 担保预计额度 | A | 本次担保前已用 | 本次担保 | 本次担保后可 用额度 | | --- | --- | --- | --- | --- | --- | | | | | 额度 B | 金额 C | | | | | | | ...

证券代码：605033 证券简称：美邦股份 公告编号：2026-002 陕西美邦药业集团股份有限公司 关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | 被担保人名称 | 本次担保金额 | 实际为其提供的担 | | 是否在前 | 本次担保 | | --- | --- | --- | --- | --- | --- | | | | 保余额（不含本次担 | | 期预计额 | 是否有反 | | | | 保金额） | | 度内 | 担保 | | 陕西美邦农资贸 易有限公司 | 4000.00 万元 | 3000.00 | 万元 | 是 | 否 | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股子公 | 28,000.00（含本次） | | 司对外担保余额（万元） | | | 对外担保余额占上市公司最近一期经 | 24.9% | | 审计净资产的比例（%） | | | 其他风险提示 | 无 | ...

Core Viewpoint - The company has signed a maximum guarantee contract with CITIC Bank for its wholly-owned subsidiary, providing a guarantee for a maximum debt principal of RMB 40 million [1] Group 1: Guarantee Details - The guarantee covers a principal amount of RMB 40 million along with corresponding interest, penalties, compound interest, default fines, damages, and costs related to the realization of the debt [1] - The guarantee has been approved by the company's board and the first extraordinary general meeting of shareholders in 2026, falling within the previously estimated guarantee limit [1] Group 2: Financial Impact - As of the announcement date, the total guarantee balance provided by the company to its wholly-owned subsidiaries amounts to RMB 280 million, which represents 24.9% of the company's audited net assets for the fiscal year 2024 [1]

Group 1 - The company, Meibang Co., Ltd. (605033.SH), has stated that it currently does not engage in export or sales activities in EU member countries [1]

Core Viewpoint - The company, Meibang Co., announced the approval of several key proposals during its first extraordinary shareholders' meeting of 2026, including the conclusion of fundraising projects and the allocation of surplus funds to enhance liquidity [2]. Group 1 - The company approved the proposal to conclude fundraising projects and permanently allocate surplus funds to enhance liquidity [2]. - The company also approved a proposal to apply for a credit limit from banks [2]. - Additionally, the company approved a proposal to provide guarantees for its subsidiaries [2].

证券代码：605033 证券简称：美邦股份 公告编号：2026-001 陕西美邦药业集团股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由董事会召集，以现场投票和网络投票相结合的方式进行表决， 会议由董事长张少武先生主持。本次会议的召集、召开程序符合《公司法》及《公 (一) 股东会召开的时间：2026 年 1 月 15 日 (二) 股东会召开的地点：陕西省西安市经济技术开发区草滩三路石羊工业园 区 A19 号楼陕西美邦药业集团股份有限公司三楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 司章程》的规定。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 94 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 98,643,300 | | 3、出席会议的股东所持有表决 ...